167 related articles for article (PubMed ID: 22936064)
41. Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
Paietta E; Racevskis J; Bennett JM; Wiernik PH
Br J Haematol; 1993 Jul; 84(3):416-22. PubMed ID: 8217792
[TBL] [Abstract][Full Text] [Related]
42. Acute myeloid leukemia with minimal differentiation. A multiple parameter study.
Cohen PL; Hoyer JD; Kurtin PJ; Dewald GW; Hanson CA
Am J Clin Pathol; 1998 Jan; 109(1):32-8. PubMed ID: 9426515
[TBL] [Abstract][Full Text] [Related]
43. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases.
Schoch C; Schnittger S; Klaus M; Kern W; Hiddemann W; Haferlach T
Blood; 2003 Oct; 102(7):2395-402. PubMed ID: 12805060
[TBL] [Abstract][Full Text] [Related]
44. Usefulness of terminal deoxynucleotidyl transferase as prognosticator in leukemia patients.
Bhatavdekar JM; Trivedi SN; Vora HH; Shukla SN
Int J Biol Markers; 1993; 8(2):77-80. PubMed ID: 8366299
[TBL] [Abstract][Full Text] [Related]
45. Terminal transferase expression in acute myeloid leukaemia: biology and prognosis.
Gucalp R; Paietta E; Weinberg V; Papenhausen P; Dutcher JP; Wiernik PH
Br J Haematol; 1991 May; 78(1):48-54. PubMed ID: 2043481
[TBL] [Abstract][Full Text] [Related]
46. Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Czerw T; Labopin M; Gorin NC; Giebel S; Blaise D; Meloni G; Pigneux A; Bosi A; Veelken J; Ferrara F; Schaap N; Lemoli RM; Cornelissen JJ; Beohou E; Nagler A; Mohty M
Cancer; 2016 Jun; 122(12):1880-7. PubMed ID: 27018549
[TBL] [Abstract][Full Text] [Related]
47. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
[TBL] [Abstract][Full Text] [Related]
48. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
49. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
50. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings.
Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Van Orshoven A; Criel A; Stul M; Dal Cin P; Hernandez J
Blood; 1995 Jun; 85(12):3688-94. PubMed ID: 7780152
[TBL] [Abstract][Full Text] [Related]
51. TdT activity in acute myeloid leukemias defined by monoclonal antibodies.
San Miguel JF; González M; Cañizo MC; Anta JP; Portero JA; López-Borrasca A
Am J Hematol; 1986 Sep; 23(1):9-17. PubMed ID: 3461712
[TBL] [Abstract][Full Text] [Related]
52. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
53. Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases.
Cascavilla N; Melillo L; D'Arena G; Greco MM; Carella AM; Sajeva MR; Perla G; Matera R; Minervini MM; Carotenuto M
Leuk Lymphoma; 2000 Mar; 37(1-2):105-13. PubMed ID: 10721774
[TBL] [Abstract][Full Text] [Related]
54. Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA.
Kansal R
Hum Pathol; 2019 Aug; 90():80-96. PubMed ID: 31077683
[TBL] [Abstract][Full Text] [Related]
55. Sterile transcription of immunoglobulin/T-cell receptor genes and other evidence of early lymphoid differentiation in acute myelogenous leukemia.
Williams L; Moscinski LC
Leukemia; 1993 Sep; 7(9):1423-31. PubMed ID: 8371592
[TBL] [Abstract][Full Text] [Related]
56. Terminal deoxynucleotidyl transferase (TdT) in acute nonlymphocytic leukemia. A clinical, morphologic, cytochemical, immunologic, and ultrastructural study.
McCurley TL; Greer JP; Glick AD
Am J Clin Pathol; 1988 Oct; 90(4):421-30. PubMed ID: 2459954
[TBL] [Abstract][Full Text] [Related]
57. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F
Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509
[TBL] [Abstract][Full Text] [Related]
58. Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group.
Weinberg OK; Hasserjian RP; Baraban E; Ok CY; Geyer JT; Philip JKSS; Kurzer JH; Rogers HJ; Nardi V; Stone RM; Garcia JS; Hsi ED; Bagg A; Wang SA; Orazi A; Arber DA
Mod Pathol; 2019 Sep; 32(9):1373-1385. PubMed ID: 31000771
[TBL] [Abstract][Full Text] [Related]
59. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia.
Benedetto P; Mertelsmann R; Szatrowski TH; Andreeff M; Gee T; Arlin Z; Kempin S; Clarkson B
J Clin Oncol; 1986 Apr; 4(4):489-95. PubMed ID: 3958762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
